Search

Your search keyword '"Bridoux, Franck"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Bridoux, Franck" Remove constraint Author: "Bridoux, Franck" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
24 results on '"Bridoux, Franck"'

Search Results

1. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

2. Mass spectrometry-based proteomics in clinical practice amyloid typing: state-of-the-art from a French nationwide cohort

5. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

6. Spectrum of Mutations in Gitelman Syndrome

8. Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series

9. Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma

10. Chronic HCV Infection and Autologous Stem Cell Transplantation for Multiple Myeloma

11. How I treat monoclonal gammopathy of renal significance (MGRS)

12. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant

13. Al amyloidosis

14. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma

15. CKD and Its Risk Factors among Patients with Cystinuria

16. The Alarmin Concept Applied to Human Renal Transplantation: Evidence for a Differential Implication of HMGB1 and IL-33

17. Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy

18. Effectiveness of Second Line Treatment in AL Amyloidosis Patients Refractory to M-Dex.

19. HGF Measurement in AL Amyloidosis.

20. Lenalidomide in Combination with Melphalan and Dexamethasone in Patients with Newly-Diagnosed Light-Chain (AL)-Amyloidosis: a Multicenter Phase I/II Dose Escalation Study.

21. A Multicenter Phase I/II Dose Escalation Study of Lenalidomide in Combination with Melphalan and Dexamethasone in Subjects with Newly-Diagnosed Light-Chain (AL)-Amyloidosis.

23. Light and heavy chain deposition disease associated with CH1 deletion.

24. Pomalidomide 3rd Line Versus 4thLine for RRMM

Catalog

Books, media, physical & digital resources